New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class c-Met directed ADC.Data from a
- iLearningEngines, Inc. (NASDAQ:AILE) ("iLearningEngines" or "ILE") a leading Applied AI platform for learning and work automation, today announced it expects to join the broad-market Russell 3000 Index at the